SynCore to analyze cancer drug as it enters next phases

SynCore Biotechnology Co (杏國新藥) is planning an interim analysis of its pancreatic cancer treatment, SB05PC, later this month to determine the drug’s safety and efficacy. The company is conducting a …
( read original story …)

---